Show results for
Refine by
Locations
- USA
- Alabama
- Alaska
- Arizona
- Arkansas
- California
- Colorado
- Connecticut
- Delaware
- District Of Columbia
- Florida
- Georgia (Us)
- Hawaii
- Idaho
- Illinois
- Indiana
- Iowa
- Kansas
- Kentucky
- Louisiana
- Maine
- Maryland
- Massachusetts
- Michigan
- Minnesota
- Mississippi
- Missouri
- Montana
- Nebraska
- Nevada
- New Hampshire
- New Jersey
- New Mexico
- New York
- North Carolina
- North Dakota
- Ohio
- Oklahoma
- Oregon
- Pennsylvania
- Rhode Island
- South Carolina
- South Dakota
- Tennessee
- Texas
- Utah
- Vermont
- Virginia
- Washington
- West Virginia
- Wisconsin
- Wyoming
Disease Symptoms Equipment Supplied In Usa
17 equipment items found
Manufactured by:Lumen Bioscience, Inc. based inSeattle, WASHINGTON (USA)
Covid-19 is widely known as a respiratory disease, but its GI symptoms are well documented. The now-famous ACE2 receptor is abundantly expressed on the cells lining the GI tract, and over half of Covid-19 sufferers show symptoms of GI distress, and up to a quarter show only GI symptoms. GI infection by the virus can have serious ...
Manufactured by:Entero Therapeutics, Inc. based inBoca Raton, FLORIDA (USA)
Latiglutenase (IMGX003) is an orally administered mixture of two gluten-specific recombinant proteases that degrades gluten proteins into small physiologically irrelevant fragments, and is to be administered as an adjunct to a gluten-free diet (GFD). As illustrated in the below figure, one protease (IMGX001) is effective at breaking glutamine-leucine bonds and the other protease (IMGX002) targets ...
by:Gain Therapeutics, Inc. based inBethesda, MARYLAND (USA)
Gaucher disease is the most common lysosomal storage disease and is caused by mutations in GBA, the gene that encodes the beta-glucocerebrosidase (GCase) enzyme. These mutations result in the misfolding and subsequent dysfunction of GCase, which leads to the toxic buildup of fat in a variety of organs and tissues such as the liver, spleen, bones and central ...
by:Verb Biotics based inBoston, MASSACHUSETTS (USA)
Yso2 is a preclinical program targeting Crohn’s disease. It aims to develop Christensenella gut bacteria as a safe, efficient and groundbreaking oral biotherapy. YSOPIA has identified a lead candidate to relieve Crohn’s disease associated symptoms and slow down disease progression. ...
Manufactured by:Great Lakes NeuroTechnologies based inCleveland, OHIO (USA)
The KinesiaU™ motor assessment system serves as a clinically validated, cost-effective prescription application designed for individuals managing Parkinson’s disease and essential tremor. This innovative system is compatible with both iPhone and Android smartphones, as well as smartwatches, allowing users to systematically track core symptoms including tremors, ...
Manufactured by:Everlywell, Inc. based inAustin, TEXAS (USA)
Test a broader set of foods that may be causing you discomfort with our most comprehensive food sensitivity offering. This test includes a wide range of foods and is ideal for people who eat a variety of cuisines. ...
Manufactured by:Neuro Device Innovations (NDI) based inCleveland, OHIO (USA)
TOPS technology was developed by Duke University Biomedical Engineering Professor, Dr. Warren Grill. After more than a decade of research, Professor Grill's lab discovered a way to 'speak' to the area of the brain that controls movement in people with Parkinson's disease. The stimulation patterns were designed to be more effective and/or more energy efficient than standard ...
by:Gain Therapeutics, Inc. based inBethesda, MARYLAND (USA)
Morquio B, also known as Mucopolysaccharidosis type IV (MPS IV), is a progressive disease mostly impacting the skeleton, caused by mutations in GLB1, the gene that encodes the beta-galactosidase (GLB) enzyme. These mutations result in the misfolding and subsequent dysfunction of GLB, which leads to the toxic substrate accumulation of keratan sulfate in organs and tissues. Very ...
by:Gain Therapeutics, Inc. based inBethesda, MARYLAND (USA)
Mucopolysaccharidosis type 1 (MPS 1) is a rare lysosomal storage disease that is caused by mutations in IDUA, the gene that encodes the alpha-L-iduronidase (IDUA) enzyme. These mutations cause the misfolding and dysfunction of IDUA, which leads to the toxic buildup of large sugars in the bone, cartilage, cornea, heart and central nervous system (CNS). There is currently no cure ...
Manufactured by:Bio Fire Diagnostics based inSalt Lake City, UTAH (USA)
With overlapping symptoms, distinguishing possible causes of gastroenteritis can be challenging for any clinician. To further complicate diagnosis, traditional testing methods are slow, labor intensive, and fail to reveal the etiology of a patient’s gastrointestinal symptoms.1 Fortunately, syndromic testing from the BioFire GI Panel eliminates limitations from conventional methods by ...
by:Gain Therapeutics, Inc. based inBethesda, MARYLAND (USA)
GM1 Gangliosidosis is a hereditary, progressive disease mostly impacting neurons in the brain and spinal cord, caused by mutations in GLB1, the gene that encodes the beta-galactosidase (GLB) enzyme. These mutations result in the misfolding and subsequent dysfunction of GLB, which leads to the toxic substrate accumulation of GM1 ganglioside in organs and tissues. Very limited and ...
Manufactured by:Gold Standard Diagnostics based inDavis, CALIFORNIA (USA)
The Mplex Monkeypox, Orthopox is a research use only (RUO) Real-time PCR assay designed for the simultaneous qualitative detection of the monkeypox virus and its differentiation from other orthopox viruses. Sample material should be DNA extracted from human upper respiratory specimen types, whole blood, serum or pustule specimen types. ...
Manufactured by:BiomX based inNess Ziona, ISRAEL
BX003 is an orally administered phage cocktail targeting a bacterial target present in the gut of IBD and PSC patients and thought to be associated with the onset or exacerbation of these diseases. Although different organs are affected in IBD and PSC (gut in IBD and liver in PSC) the two diseases are thought to be related since approximately 70% of PSC patients also suffer from IBD. Results from ...
Manufactured by:KORU Medical Systems based inMahwah, NEW JERSEY (USA)
Chronic inflammatory demyelinating polyneuropathy, or CIDP, is a rare disorder characterized by gradually increasing sensory loss and weakness associated with loss of reflexes. This is caused by an autoimmune process in which the body’s own immune system doesn’t recognize its nerve fibers and attacks them. This leads to inflammation of nerve roots and peripheral nerves, as well as ...
Manufactured by:Ocugen, Inc. based inMalvern, PENNSYLVANIA (USA)
OCU200 is a biologic product candidate in preclinical development for treating severely sight-threatening diseases like Diabetic Macular Edema (DME), Diabetic Retinopathy (DR), and Wet Age-Related Macular Degeneration (Wet-AMD). Patients affected by these diseases share common symptoms, such as blurriness in vision and progressive vision loss as ...
Manufactured by:Forge Biologics, Inc. based inGrove City, OHIO (USA)
Krabbe disease is a devastating neurodegenerative disease affecting about 1 -2.5 in 100,000 people in the U.S. and is inherited in an autosomal recessive manner. Krabbe disease is caused by loss-of-function mutations in the galactosylceramidase (GALC) gene, a lysosomal enzyme responsible for the breakdown of certain types of lipids such as psychosine. Without functional GALC, psychosine ...
Manufactured by:Nirmidas Biotech, Inc. based inPalo Alto, CALIFORNIA (USA)
The test can be used for a variety of samples including serum, plasma, whole blood, dry blood spot, and saliva in a lab facility. It can be used to assess IgG and IgM levels in a sample with 100% sensitivity and 99.87% specificity without interferences from other diseases. Avidity pGOLD™ assay can tell if a COVID-19 infection is recent or remote greater than 6 months ...